GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Visioneering Technologies Inc (ASX:VTI) » Definitions » Net-Net Working Capital

Visioneering Technologies (ASX:VTI) Net-Net Working Capital : A$0.08 (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Visioneering Technologies Net-Net Working Capital?

In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. This is a conservative way of estimating the company's value.

Visioneering Technologies's Net-Net Working Capital for the quarter that ended in Dec. 2023 was A$0.08.

The industry rank for Visioneering Technologies's Net-Net Working Capital or its related term are showing as below:

ASX:VTI's Price-to-Net-Net-Working-Capital is ranked better than
91.67% of 456 companies
in the Medical Devices & Instruments industry
Industry Median: 6.495 vs ASX:VTI: 1.50

Visioneering Technologies Net-Net Working Capital Historical Data

The historical data trend for Visioneering Technologies's Net-Net Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Visioneering Technologies Net-Net Working Capital Chart

Visioneering Technologies Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net-Net Working Capital
Get a 7-Day Free Trial -0.44 -0.44 0.44 0.17 0.08

Visioneering Technologies Semi-Annual Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Net-Net Working Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.44 0.26 0.17 0.08 0.08

Competitive Comparison of Visioneering Technologies's Net-Net Working Capital

For the Medical Devices subindustry, Visioneering Technologies's Price-to-Net-Net-Working-Capital, along with its competitors' market caps and Price-to-Net-Net-Working-Capital data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Visioneering Technologies's Price-to-Net-Net-Working-Capital Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Visioneering Technologies's Price-to-Net-Net-Working-Capital distribution charts can be found below:

* The bar in red indicates where Visioneering Technologies's Price-to-Net-Net-Working-Capital falls into.



Visioneering Technologies Net-Net Working Capital Calculation

Visioneering Technologies's Net-Net Working Capital (NNWC) per share for the fiscal year that ended in Dec. 2023 is calculated as

Net-Net Working Capital(A: Dec. 2023 )
=(Cash, Cash Equivalents, Marketable Securities+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(4.481+0.75 * 1.443+0.5 * 3.229-2.821
-0-0)/51.2939
=0.08

Visioneering Technologies's Net-Net Working Capital (NNWC) per share for the quarter that ended in Dec. 2023 is calculated as

Net-Net Working Capital(Q: Dec. 2023 )
=(Cash, Cash Equivalents, Marketable Securities+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(4.481+0.75 * 1.443+0.5 * 3.229-2.821
-0-0)/51.2939
=0.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full.

In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

This is a conservative way of estimating the company's value.


Visioneering Technologies  (ASX:VTI) Net-Net Working Capital Explanation

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their net-net value. They are collected under our Net-Net screener.


Visioneering Technologies Net-Net Working Capital Related Terms

Thank you for viewing the detailed overview of Visioneering Technologies's Net-Net Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Visioneering Technologies (ASX:VTI) Business Description

Traded in Other Exchanges
N/A
Address
10745 Westside Way, Suite 200, Alpharetta, GA, USA, 30009
Visioneering Technologies Inc is a medical device company. It designs, manufactures, sales and distributes its NaturalVue daily disposable multifocal contact lenses for adults with Presbyopia and children with Myopia. The company offers NaturalVue MF contact lenses. Its Multifocal contact lens provides Presbyopia patients with near, intermediate, and distance vision and which is much easier for eye care professionals to fit their patients.

Visioneering Technologies (ASX:VTI) Headlines

From GuruFocus

Northstar Group, Inc. Buys 2, Sells 3 in 4th Quarter

By GuruFocus Research GuruFocus Editor 01-26-2023

Top 5 4th Quarter Trades of Novo Holdings A/S

By GuruFocus Research GuruFocus Editor 02-18-2023

CONTINENTAL INVESTORS SERVICES, INC.'s Top 5 Buys of the 3rd Quarter

By GuruFocus Research GuruFocus Editor 11-23-2022

Top 5 4th Quarter Trades of H&H Retirement Design & Management INC

By GuruFocus Research GuruFocus Editor 01-17-2023

Top 5 4th Quarter Trades of Greenfield Savings Bank

By GuruFocus Research GuruFocus Editor 01-13-2023

Top 5 3rd Quarter Trades of Patriot Investment Management Inc.

By GuruFocus Research GuruFocus Editor 11-03-2022

Gleason Group, Inc. Goes on Buying Spree in 4th Quarter

By GuruFocus Research GuruFocus Editor 01-11-2023

McClarren Financial Advisors, Inc. Goes on Buying Spree in 4th Quarter

By GuruFocus Research GuruFocus Editor 01-31-2023

Top 5 4th Quarter Trades of Peterson Wealth Advisors, LLC

By GuruFocus Research GuruFocus Editor 01-21-2023

Top 5 3rd Quarter Trades of Gibson Wealth Advisors LLC

By GuruFocus Research GuruFocus Editor 11-23-2022